Two Fears That Got Tangled Together
Almost every week, someone in our community asks the same worried question: “I heard NexGard can cause seizures, and my dog has MDR1 — is that why?”
It’s a completely reasonable thing to assume. You’ve learned that herding breeds are sensitive to certain drugs. You’ve also seen the FDA warning about flea and tick chews and neurological reactions. Your brain connects the two dots, and now you’re afraid to give your dog any parasite protection at all.
Here’s the truth, and it’s genuinely good news: those are two separate issues, and the one that actually involves MDR1 isn’t the one you’re worried about. Let me pull them apart, because understanding the difference changes how you protect your dog — and it usually means you have more safe options, not fewer.
What the Isoxazoline Chews Actually Are
NexGard (afoxolaner), Bravecto (fluralaner), Simparica (sarolaner), and Credelio (lotilaner) all belong to the same drug class: the isoxazolines. They kill fleas and ticks by overstimulating the parasite’s nervous system — specifically by acting on insect GABA- and glutamate-gated chloride channels.
They’re enormously popular because they work well and last a long time, from a month to twelve weeks depending on the product. And because they’re newer and the FDA flagged a safety concern about them, they’ve become a lightning rod for worry among MDR1 owners.
Why MDR1 Is Not the Problem Here
This is the part that should ease your mind. Isoxazolines are not dangerous because of the MDR1 mutation.
The MDR1 gene controls P-glycoprotein, a pump at the blood-brain barrier that ejects certain drugs out of the brain. Drugs like ivermectin and loperamide are problems in MDR1 dogs precisely because they’re strong P-glycoprotein substrates — when the pump is broken, they flood the central nervous system. (We explain that mechanism in plain language in our piece on how the MDR1 mutation works.)
Isoxazolines don’t behave that way. They have low penetration into the mammalian brain and are not the kind of strong P-glycoprotein substrates that ivermectin is. The manufacturers’ safety studies — including testing in Collies and in MDR1-affected dogs — found these products were well tolerated at, and above, the labeled dose. In other words, having one or two copies of the MDR1 mutation does not make a dog meaningfully more sensitive to a flea and tick chew.
There’s even an upside. Because isoxazolines are safe across MDR1 genotypes, they’ve become the recommended treatment for demodectic and sarcoptic mange in herding breeds — replacing the high-dose ivermectin that used to put mutant/mutant dogs in mortal danger. The very drug class people fear is one of the safest tools we have for these dogs.
So What Is the FDA Warning About?
In 2018, the FDA issued an alert about the isoxazoline class as a whole. In a small number of dogs — regardless of breed or MDR1 status — these drugs have been associated with neurological adverse events: muscle tremors, ataxia (incoordination), and seizures.
The key phrase is regardless of MDR1 status. This is a pharmacodynamic effect — a rare, idiosyncratic reaction to how the drug acts on the nervous system — not a pharmacokinetic P-glycoprotein problem. It can theoretically happen in any dog. A normal/normal Labrador is subject to the same warning as a mutant/mutant Collie.
So the warning is real, and worth respecting. But it has nothing to do with the genetic sensitivity this whole site is built around. It’s a separate box on the risk chart.
The Practical Difference: P-gp vs. a Neuro Event
It helps to hold the two ideas side by side:
- A P-glycoprotein (MDR1) problem is about a broken pump letting a drug into the brain. It’s predictable, dose-related, and tied to specific substrate drugs like ivermectin. Your dog’s genotype tells you the risk.
- A general neurologic adverse event (the isoxazoline FDA warning) is about a rare, individual reaction to the drug itself. It isn’t predicted by MDR1 status. The biggest known risk factor is a dog’s own history of seizures or neurological disease.
Knowing which kind of risk you’re dealing with tells you what actually matters when you choose a product.
How to Choose a Parasite Protocol for a Herding Breed
For most MDR1-affected herding dogs, an isoxazoline is a perfectly reasonable, safe choice for flea and tick control. The decision tree is simple:
If your dog has no history of seizures or neurological disease: Isoxazolines (NexGard, Bravecto, Simparica, Credelio) are safe with respect to MDR1, and the general adverse-event risk is low. Many herding-breed owners use them without incident.
If your dog has a seizure history or a neurological condition: This is where the FDA warning earns real weight — not because of MDR1, but because seizure-prone dogs may be more vulnerable to that rare reaction. Talk to your vet about topical alternatives. Older topicals like fipronil (Frontline) and imidacloprid-based products are not isoxazolines, are not MDR1 concerns, and sidestep that specific warning.
One detail worth knowing about combination products: Simparica Trio adds moxidectin to cover heartworm. Moxidectin is a macrocyclic lactone — the same family as ivermectin — but at the low heartworm-prevention dose it carries, it’s considered safe across MDR1 genotypes, the same way low-dose ivermectin in Heartgard is. The plain Simparica chew contains only sarolaner and no macrocyclic lactone. If you prefer to keep your heartworm and flea/tick decisions separate, that’s a legitimate reason to choose the single-ingredient version.
For the wider conversation about which preventives belong in a herding breed’s routine, our prevention and practical tools resources lay out the full picture.
The Bottom Line
Don’t let two tangled fears talk you out of protecting your dog. Fleas carry tapeworms; ticks carry Lyme, anaplasmosis, and worse. Going unprotected is its own serious risk, and for a herding dog it’s an unnecessary one.
The honest summary is this: isoxazoline chews are not a special danger to MDR1 dogs — your dog’s genotype barely enters into it. The FDA’s seizure warning is real but applies to all dogs and matters most if yours already has a neurological history. Match the product to that fact, loop in your vet, and your herding breed can be fully protected without you lying awake over the wrong worry.
Unsure whether a flea and tick product is right for your dog’s specific history? Contact us and we’ll help you frame the question for your vet. You can also browse families’ real experiences in our community stories.